BR112012003435A2 - formas anidras de um derivado de píridina - Google Patents

formas anidras de um derivado de píridina

Info

Publication number
BR112012003435A2
BR112012003435A2 BR112012003435A BR112012003435A BR112012003435A2 BR 112012003435 A2 BR112012003435 A2 BR 112012003435A2 BR 112012003435 A BR112012003435 A BR 112012003435A BR 112012003435 A BR112012003435 A BR 112012003435A BR 112012003435 A2 BR112012003435 A2 BR 112012003435A2
Authority
BR
Brazil
Prior art keywords
pyridine derivative
anhydrous forms
anhydrous
forms
pyridine
Prior art date
Application number
BR112012003435A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112012003435B1 (pt
Inventor
Andrew Simon Craig
Ronnie Maxwell Lawrence
Salima Zarah Ismail
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Publication of BR112012003435A2 publication Critical patent/BR112012003435A2/pt
Publication of BR112012003435B1 publication Critical patent/BR112012003435B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR112012003435-9A 2009-08-27 2010-08-25 Composto na forma cristalina anidra, composição farmacêutica compreendendo dito composto e uso terapêutico do mesmo BR112012003435B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23743509P 2009-08-27 2009-08-27
US61/237.435 2009-08-27
PCT/EP2010/062420 WO2011023733A1 (en) 2009-08-27 2010-08-25 Anhydrate forms of a pyridine derivative

Publications (2)

Publication Number Publication Date
BR112012003435A2 true BR112012003435A2 (pt) 2016-02-23
BR112012003435B1 BR112012003435B1 (pt) 2026-01-21

Family

ID=

Also Published As

Publication number Publication date
JP2016000739A (ja) 2016-01-07
IL217922A0 (en) 2012-03-29
WO2011023733A1 (en) 2011-03-03
US8796269B2 (en) 2014-08-05
ES2440938T3 (es) 2014-01-31
PL2470545T3 (pl) 2014-03-31
US20120157450A1 (en) 2012-06-21
EA201270302A1 (ru) 2012-07-30
CA2772168C (en) 2019-01-08
CN102639536B (zh) 2015-03-18
ZA201200812B (en) 2013-03-27
JP6404186B2 (ja) 2018-10-10
AU2010288502B2 (en) 2013-12-12
IN2012DN01292A (enExample) 2015-06-05
EP2470545B1 (en) 2013-10-09
CN102639536A (zh) 2012-08-15
CA2772168A1 (en) 2011-03-03
JP2013503134A (ja) 2013-01-31
JP2017193564A (ja) 2017-10-26
KR20120056258A (ko) 2012-06-01
MX2012002369A (es) 2012-03-29
SG178231A1 (en) 2012-03-29
AU2010288502A1 (en) 2012-02-23
IL217922A (en) 2016-06-30
DK2470545T3 (da) 2014-01-13
EA021411B1 (ru) 2015-06-30
EP2470545A1 (en) 2012-07-04

Similar Documents

Publication Publication Date Title
LTPA2017017I1 (lt) Tetraciklinis junginys
EP2404918A4 (en) pyridine
BRPI1013246A2 (pt) derivados de benzofuralina
BR112012002828A2 (pt) derivados de 5-fluorpirimidinona
ECSP12011999A (es) Derivados benzamida sustituidos
EP2433940A4 (en) SPIROIMIDAZOLONDERIVAT
BRPI1013844A2 (pt) derivados de piridina-isoxazol
EP2397480A4 (en) DIAZEPINEDIONEDERIVATE
BRPI1014454A2 (pt) derivados de isoxazol-pirazol
BR112012002810A2 (pt) derivados de n1-acil-5-fluoropirimidinona
DK2387580T3 (da) Deoxyactagardinderivater
EP2401281A4 (en) PYRIMIDINPYRIMIDOINDAZOLDERIVAT
DK2339208T3 (da) Gear
PT2492266E (pt) Derivado de 5-hidroxipirimidino-4-carboxamida
DK2453858T3 (da) Fremgangsmåde
BRPI1011416A2 (pt) derivados de antraquinova novos
BRPI0923528A2 (pt) engrenagem intermediária
BRPI0917224A2 (pt) formas cristalinas de um derivado de piridina
BRPI1010740A2 (pt) novos derivados de ciclopentano
EP2463290A4 (en) THIENOXAZEPINDERIVAT
BRPI1007893A2 (pt) derivado de cianopirimidina
IT1393323B1 (it) Orologio da polso
BR112012003435A2 (pt) formas anidras de um derivado de píridina
FI9141U1 (fi) Apuväline
CN301308131S (zh) 手表

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B03G Publication of an application: publication cancelled [chapter 3.7 patent gazette]

Free format text: REFERENTE A RPI 2355 DE 23/02/2016, POR TER SIDO INDEVIDO

B25C Requirement related to requested transfer of rights

Owner name: GLAXOSMITHKLINE LLC (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: NERRE THERAPEUTICS LIMITED (GB)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25A Requested transfer of rights approved

Owner name: KANDY THERAPEUTICS LIMITED (GB)

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/08/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.